Director, Quality Control

Decoding The Role

The Quality team is seeking a highly motivated and experienced technical and organizational leader in gRNA, mRNA, and Lipid Nanoparticle (LNP) analytical methodologies and GMP testing. The successful candidate will collaborate with a high‑performing CMC team, coordinating with process and analytical experts cross‑functionally in Research and Discovery, Process Development, Analytical Sciences, Manufacturing, and Quality Assurance, to transfer, qualify and oversee in‑process and release testing to advance Editas’ in‑vivo gene medicine portfolio.

The individual will also be a key contributor to the overall program CMC strategy. This role requires strong analytical expertise, GMP experience, as well as a passion to lead, mentor and influence people.

• Lead phase‑appropriate CMC analytical development, qualification/validation, transfer and optimization through strong collaboration with key stakeholders and external partners.
• Drive the analytical control strategy for in‑vivo medicines towards IND/CTA and clinical manufacturing.
• Ensure seamless transition of analytics from Analytical Sciences and into GMP manufacturing.
• Collaborate with QA to generate, review and approve documentation, including SOPs, change controls, deviations, CAPAs and OOS/OOT investigation reports.
• Act as the lead Subject Matter Expert for gRNA, mRNA, and drug delivery (e.g., LNP) control strategy.
• Establish phase‑appropriate specifications based on sound scientific rationale for critical starting materials (e.g., pDNA), drug substance (e.g., gRNA and mRNA), excipients (e.g., lipids and targeting moieties), and drug product (e.g., LNP).
• Oversee the external GMP testing of critical starting materials, novel excipients, drug substance and drug product for clinical use.
• Implement stability programs to establish the retest dates/shelf life of critical starting materials, novel excipients, drug substance and drug product for clinical use.
• Lead cross‑functional projects/working teams, champion new ideas/business process improvements to advance the company’s in‑vivo pipeline and technology platforms.
• Author and review regulatory submissions, technical reports, SOPs and work instructions.
• Stay up to date with the latest industry trends and product knowledge.
• Work cross‑functionally (e.g., with Research, Business Development and Legal) to evaluate novel manufacturing technologies and new business partners.

• Degree in Microbiology, Biomedical Engineering, Chemistry, Pharmaceutical Sciences, or related discipline with 8+ years of relevant experience (Ph.D.) or 10+ years (M.S.) or 12+ years (B.S.).
• Strong technical expertise and hands‑on experience with analytical test method optimization, validation, and transfers as well as CTO/CMO management.
• In‑depth expertise in critical raw material, drug substance, and drug product characterization methods and specifications.
• Ability to develop analytical control strategies that are phase‑appropriate (e.g., phase 1 vs. phase
  3) and grounded in risk‑management principles.
• Ability to apply Quality‑by‑Design (QbD) principles to process development strategy planning and execution.
• Exceptional leadership and interpersonal skills with excellent presentation, scientific and technical writing abilities.
• Strong organizational skills and ability to multi‑task, problem‑solve, and adjust priorities to meet goals in a fast‑paced environment.
• Experience in leading cross‑functional collaborations with internal departments and external CDMOs.
• Understanding of FDA, PDA, ICH and BPOG guidance, knowledge of FDA, EMA and ICH regulations, and familiarity with the product development life cycle.

Editas provides a comprehensive array of benefits to all employees, including a Blue Cross Blue Shield PPO Medical Plan, a company‑funded Health Savings Account, Dental and Vision Insurance, Life and Disability Insurance, Dependent Care Account, Tuition Reimbursement, 401(k) plan with company match, Employee Assistance Plan, Wellness Programs, and a flexible Paid Time Off policy.

$215,000 - $235,000

Editas Medicine is committed to transparency and accuracy in its hiring practices. The anticipated salary range for each position is posted within the role. The final salary offer will be determined based on a comprehensive assessment of the candidate’s qualifications, including education, training, and relevant experience. Additional factors such as external market conditions, the role’s criticality, and internal equity will also be considered.

Editas Medicine’s compensation philosophy ensures fair and equitable pay practices.